Join
Live feed
·
INSIDERFilingvia Quantisnow
Sigilon Therapeutics Inc. logo

SEC Form 4: Kowalsky Matthew Paul returned 1,925 shares to the company, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
SGTX· Sigilon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGTX (Sigilon Therapeutics Inc.) and more on Quantisnow.